The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Interim safety analysis of the DANTE trial: Perioperative atezolizumab in combination with FLOT versus FLOT alone in patients with resectable esophagogastric adenocarcinoma—A randomized, open-label phase II trial of the German Gastric Group at the AIO and SAKK.
 
Nils Homann
No Relationships to Disclose
 
Sylvie Lorenzen
No Relationships to Disclose
 
Michael Schenk
No Relationships to Disclose
 
Peter C. Thuss-Patience
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Merck Serono; MSD; Roche; SERVIER
Research Funding - Merck Serono (Inst)
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche; Sanofi; SERVIER
 
Ralf Dieter Hofheinz
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Medac; Merck Serono; MSD; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst); Medac (Inst); Sanofi (Inst)
 
Albrecht Kretzschmar
Honoraria - Amgen; Eisai; Medac; Merck Serono; Novartis; Roche Pharma AG; Sanofi; SERVIER; Shire
Consulting or Advisory Role - Amgen; Roche Pharma AG; Shire; Teva
Travel, Accommodations, Expenses - Ipsen; Medac; Merck Serono; PharmaMar
 
Claus Bolling
Research Funding - MOLOGEN; PledPharma
 
Stefan Angermeier
No Relationships to Disclose
 
Andreas Wicki
No Relationships to Disclose
 
Alexander Rheinhard Siebenhuener
No Relationships to Disclose
 
Udo Lindig
No Relationships to Disclose
 
Daniel Pink
Employment - Helios Kliniken GmbH
Consulting or Advisory Role - Clinigen Group (Inst); Lilly (Inst); Roche (Inst)
Research Funding - Clinigen Group (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
 
Thomas Jens Ettrich
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi/Aventis
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Harald Schmalenberg
No Relationships to Disclose
 
Lisa Waberer
No Relationships to Disclose
 
Jonathan Talbot
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Lilly; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - Deutsche Forschungsgemeinschaft; Gemeinsamer Bundesausschuss
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma